FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

38112003: 1 (qualifier value)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    64719019 One en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442105014 1 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    33081000077110 un fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    un Is a General adjectival modifier false Inferred relationship Some
    un Is a nombre false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Eliglustat (as eliglustat tartrate) 84 mg oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely ixazomib (as ixazomib citrate) 4 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely ixazomib (as ixazomib citrate) 4 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely panobinostat (as panobinostat lactate) 20 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely panobinostat (as panobinostat lactate) 20 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Ixazomib (as ixazomib citrate) 3 mg oral capsule Count of base of active ingredient False un Inferred relationship Some
    Ixazomib (as ixazomib citrate) 3 mg oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely ixazomib (as ixazomib citrate) 2.3 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely ixazomib (as ixazomib citrate) 2.3 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely lomitapide (as lomitapide mesilate) 5 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely lomitapide (as lomitapide mesilate) 5 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely lomitapide (as lomitapide mesilate) 10 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely lomitapide (as lomitapide mesilate) 10 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely lomitapide (as lomitapide mesilate) 20 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely lomitapide (as lomitapide mesilate) 20 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing only lomitapide (medicinal product) Count of base of active ingredient False un Inferred relationship Some
    Product containing only lomitapide in oral dose form (medicinal product form) Count of base of active ingredient False un Inferred relationship Some
    Silver sulfadiazine 10 mg/g cutaneous cream Count of base of active ingredient False un Inferred relationship Some
    Silver sulfadiazine 10 mg/g cutaneous cream Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely isavuconazole (as isavuconazonium sulfate) 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely isavuconazole (as isavuconazonium sulfate) 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Cabozantinib (as cabozantinib s-malate) 20 mg oral capsule Count of base of active ingredient False un Inferred relationship Some
    Cabozantinib (as cabozantinib s-malate) 20 mg oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
    Silver sulfadiazine only product in cutaneous dose form Count of base of active ingredient False un Inferred relationship Some
    Silver sulfadiazine only product Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely cabozantinib (as cabozantinib s-malate) 80 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely cabozantinib (as cabozantinib s-malate) 80 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Nintedanib (as nintedanib esilate) 100 mg oral capsule Count of base of active ingredient False un Inferred relationship Some
    Nintedanib (as nintedanib esilate) 100 mg oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
    Isavuconazonium only product in parenteral dose form Count of base of active ingredient False un Inferred relationship Some
    Rabies human immune globulin only product in parenteral dose form Count of base of active ingredient False un Inferred relationship Some
    Product containing only eliglustat in oral dose form (medicinal product form) Count of base of active ingredient False un Inferred relationship Some
    Product containing only afamelanotide in parenteral dose form (medicinal product form) Count of base of active ingredient False un Inferred relationship Some
    Vaccine product containing only Neisseria meningitidis capsular polysaccharide antigen (medicinal product) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely glucosamine (as glucosamine sulfate potassium chloride) 400 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely glucosamine (as glucosamine sulfate potassium chloride) 400 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Colecalciferol 25 microgram oral capsule Count of base of active ingredient False un Inferred relationship Some
    Colecalciferol 25 microgram oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely colecalciferol 175 microgram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely colecalciferol 175 microgram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Colecalciferol 625 microgram oral capsule Count of base of active ingredient False un Inferred relationship Some
    Colecalciferol 625 microgram oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
    Colecalciferol 625 microgram/mL oral solution Count of base of active ingredient False un Inferred relationship Some
    Colecalciferol 625 microgram/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 1
    Remdesivir only product Count of base of active ingredient False un Inferred relationship Some
    Remdesivir only product in parenteral dose form Count of base of active ingredient False un Inferred relationship Some
    Remdesivir 100 mg powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
    Remdesivir 100 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
    Bempedoic acid only product Count of base of active ingredient False un Inferred relationship Some
    Product containing only bempedoic acid in oral dose form (medicinal product form) Count of base of active ingredient False un Inferred relationship Some
    Bempedoic acid 180 mg oral tablet Count of base of active ingredient False un Inferred relationship Some
    Bempedoic acid 180 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely bempedoic acid 180 milligram and ezetimibe 10 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely bempedoic acid 180 milligram and ezetimibe 10 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
    Selumetinib only product Count of base of active ingredient False un Inferred relationship Some
    Selumetinib only product in oral dose form Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely selumetinib 25 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely selumetinib 25 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely selumetinib 10 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely selumetinib 10 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing only human tetanus immunoglobulin in parenteral dose form (medicinal product form) Count of base of active ingredient False un Inferred relationship Some
    Equine diphtheria antitoxin only product in parenteral dose form Count of base of active ingredient False un Inferred relationship Some
    Equine diphtheria antitoxin only product Count of base of active ingredient False un Inferred relationship Some
    Pemigatinib 4.5 mg oral tablet Count of base of active ingredient False un Inferred relationship Some
    Pemigatinib 4.5 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Pemigatinib 9 mg oral tablet Count of base of active ingredient False un Inferred relationship Some
    Pemigatinib 9 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Pemigatinib 13.5 mg oral tablet Count of base of active ingredient False un Inferred relationship Some
    Pemigatinib 13.5 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing only pemigatinib in oral dose form (medicinal product form) Count of base of active ingredient False un Inferred relationship Some
    Product containing only pemigatinib (medicinal product) Count of base of active ingredient False un Inferred relationship Some
    Tucatinib 50 mg oral tablet Count of base of active ingredient False un Inferred relationship Some
    Tucatinib 50 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely tucatinib 150 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely tucatinib 150 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Tucatinib only product in oral dose form Count of base of active ingredient False un Inferred relationship Some
    Product containing only tucatinib (medicinal product) Count of base of active ingredient False un Inferred relationship Some
    Francisella tularensis antigen only vaccine product Count of base of active ingredient False un Inferred relationship Some
    Vaccine product containing only Yellow fever virus antigen (medicinal product) Count of base of active ingredient False un Inferred relationship Some
    Yersinia pestis antigen only vaccine product Count of base of active ingredient False un Inferred relationship Some
    Tick-borne encephalitis virus antigen only vaccine product Count of base of active ingredient False un Inferred relationship Some
    Vaccine product containing only Dengue virus antigen (medicinal product) Count of base of active ingredient False un Inferred relationship Some
    Vaccine product containing only Ebolavirus antigen (medicinal product) Count of base of active ingredient False un Inferred relationship Some
    Adenovirus antigen only vaccine product Count of base of active ingredient False un Inferred relationship Some
    Coxiella burnetii antigen only vaccine product Count of base of active ingredient False un Inferred relationship Some
    Japanese encephalitis virus antigen only vaccine product Count of base of active ingredient False un Inferred relationship Some
    Vaccine product containing only inactivated whole Japanese encephalitis virus antigen (medicinal product) Count of base of active ingredient False un Inferred relationship Some
    Rabies lyssavirus antigen only vaccine product Count of base of active ingredient False un Inferred relationship Some
    Vaccine product containing only Vaccinia virus antigen (medicinal product) Count of base of active ingredient False un Inferred relationship Some
    Corynebacterium diphtheriae antigen only vaccine product Count of base of active ingredient False un Inferred relationship Some
    Low dose Corynebacterium diphtheriae antigen only vaccine product Count of base of active ingredient False un Inferred relationship Some
    Rubella virus antigen only vaccine product Count of base of active ingredient False un Inferred relationship Some
    Mumps orthorubulavirus antigen only vaccine product Count of base of active ingredient False un Inferred relationship Some
    Vaccine product containing only live attenuated Mumps orthorubulavirus antigen (medicinal product) Count of base of active ingredient False un Inferred relationship Some
    Vaccine product containing only Human poliovirus antigen (medicinal product) Count of base of active ingredient False un Inferred relationship Some
    Inactivated whole Human poliovirus antigen only vaccine product Count of base of active ingredient False un Inferred relationship Some
    Vaccine product containing only Clostridium tetani antigen (medicinal product) Count of base of active ingredient False un Inferred relationship Some
    Cytomegalovirus antibody only product in parenteral dose form Count of base of active ingredient False un Inferred relationship Some
    Hepatitis A virus antigen only paediatric vaccine product Count of base of active ingredient False un Inferred relationship Some
    Hepatitis A virus antigen only adult vaccine product Count of base of active ingredient False un Inferred relationship Some
    Vaccine product containing only Hepatitis A virus antigen (medicinal product) Count of base of active ingredient False un Inferred relationship Some

    Start Previous Page 209 of 215 Next End

    Reference Sets

    Concept inactivation indicator reference set

    Back to Start